Factors involved in CLL pathogenesis and cell survival are disrupted by differentiation of CLL B-cells into antibody-secreting cells-Reference-Cited by-同舟云学术

Factors involved in CLL pathogenesis and cell survival are disrupted by differentiation of CLL B-cells into antibody-secreting cells

Published:2015-05-11 Issue:21 Volume:6 Page:18484-18503
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Ghamlouch Hussein¹²³,Darwiche Walaa⁴,Hodroge Ahmed¹,Ouled-Haddou Hakim¹,Dupont Sébastien¹³,Singh Amrathlal Rabbind¹,Guignant Caroline¹²,Trudel Stéphanie¹⁵,Royer Bruno¹³,Gubler Brigitte¹²⁵,Marolleau Jean-Pierre¹³

Affiliation:

1. EA4666, LNPC, Université de Picardie Jules Verne, Amiens, France

2. Department of Immunology, Amiens University Medical Center, Amiens, France

3. Department of Clinical Hematology and Cell Therapy, Amiens University Medical Center, Amiens, France

4. PériTox, Périnatalité & Risques Toxiques, UMR-I 01 Unité mixte INERIS, Amiens, France

5. Department of Molecular Oncobiology, Amiens University Medical Center, Amiens, France

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. PROteolysis‐Targeting Chimeras (PROTACs) in leukemia: overview and future perspectives;MedComm;2024-06

2. Oncotherapy resistance explained by Darwinian and Lamarckian models;Journal of Clinical Investigation;2024-04-15

3. Ex vivo culture of malignant primary B cells;Frontiers in Hematology;2022-10-19

4. In Vitro and In Vivo Models of CLL–T Cell Interactions: Implications for Drug Testing;Cancers;2022-06-23

5. Ascorbic acid (vitamin C) synergistically enhances the therapeutic effect of targeted therapy in chronic lymphocytic leukemia;Journal of Experimental & Clinical Cancer Research;2020-10-28